21. Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer. Issue 1 (1st January 2007) Authors: Vandenput, I.; Amant, F.; Neven, P.; Berteloot, P.; Leunen, K.; Vergote, I. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 1(2007) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Efficacy of CDK 4/6 inhibition after fulvestrant in metastatic breast cancer. (April 2018) Authors: Hoste, G.; Punie, K.; Wildiers, H.; Neven, P.; Vergote, I.; Beuselinck, B.; Concin, N.; Han, S.; Van Nieuwenhuysen, E.; Salihi, R.; Smeets, A.; Berteloot, P.; Lefever, I.; Nevelsteen, I.; Van Limbergen, E.; Weltens, C.; Janssen, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. GEMCITABINE IN RECURRENT PLATINUM AND PACLITAXEL RESISTANT OVARIAN CARCINOMA: AN ANALYSIS OF 50 CASES. Issue 1 (1st March 2003) Authors: D'Agostino, G.; Amant, F.; Berteloot, P.; Neven, P.; Scambia, G.; Vergote, I. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients. (1st January 2006) Authors: Fuso, L.; Amant, F.; Neven, P.; Berteloot, P.; Vergote, I. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 1 Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients. (March 2016) Authors: Lintermans, A.; Van Asten, K.; Jongen, L.; Van Brussel, T.; Laenen, A.; Verhaeghe, J.; Vanderschueren, D.; Lambrechts, D.; Neven, P. Journal: European journal of cancer Issue: Volume 56(2016) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients. (March 2016) Authors: Lintermans, A.; Van Asten, K.; Jongen, L.; Van Brussel, T.; Laenen, A.; Verhaeghe, J.; Vanderschueren, D.; Lambrechts, D.; Neven, P. Journal: European journal of cancer Issue: Volume 56(2016) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?. Issue 1 (February 2014) Authors: Dieudonné, A. S.; De Nys, K.; Casteels, M.; Wildiers, H.; Neven, P. Journal: Acta clinica belgica Issue: Volume 69:Issue 1(2014) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?. Issue 1 (February 2014) Authors: Dieudonné, A. S.; De Nys, K.; Casteels, M.; Wildiers, H.; Neven, P. Journal: Acta clinica belgica Issue: Volume 69:Issue 1(2014) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. INDICATIONS FOR AND FINDINGS AT DUCT EXCISION FOR SINGLE DUCT NIPPLE DISCHARGE. Issue 1 (1st March 2003) Authors: De Brauwer, B.; Cochet, L.; Servaes, D.; Van Ongeval, C.; Van Steen, A.; Berteloot, P.; Amant, F.; Vergote, I. B.; Christiaens, M.-R.; Neven, P. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Inter-rater reliability in the assessment of stromal characteristics in ductal carcinoma in situ of the breast: how consistent are we?. (March 2017) Authors: Van Bockstal, M.; Lambein, K.; Smeets, A.; Van Ongeval, C.; Neven, P.; Nevelsteen, I.; Christiaens, M.-R.; Wildiers, H.; Libbrecht, L.; Floris, G. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗